An Application of the Patient Rule-Induction Method to Detect Clinically Meaningful Subgroups from Failed Phase III Clinical Trials

por Dyson, Greg
Publicado 2021

High-flow nasal cannula therapy in a predominantly African American population with COVID-19 associated acute respiratory failure

por Nguyen, Paul L, Osman, Heba, Watza, Donovan, Khicher, Suman, Sharma, Aditi, Dyson, Greg, Saydain, Ghulam, Soubani, Ayman
Publicado 2021

Hyperglycemia and O-GlcNAc transferase activity drive a cancer stem cell pathway in triple-negative breast cancer

por Ayodeji, Saheed A., Bao, Bin, Teslow, Emily A., Polin, Lisa A., Dyson, Greg, Bollig-Fischer, Aliccia, Fehl, Charlie
Publicado 2023

Role of novel cancer gene SLITRK3 to activate NTRK3 in squamous cell lung cancer

por Bollig-Fischer, Aliccia, Bao, Bin, Manning, Morenci, Dyson, Greg, Michelhaugh, Sharon K., Mittal, Sandeep, Bepler, Gerold, Mamdani, Hirva
Publicado 2021

Obesity‐induced MBD2_v2 expression promotes tumor‐initiating triple‐negative breast cancer stem cells

por Teslow, Emily A., Mitrea, Cristina, Bao, Bin, Mohammad, Ramzi M., Polin, Lisa A., Dyson, Greg, Purrington, Kristen S., Bollig‐Fischer, Aliccia
Publicado 2019

Exogenous IL‐6 induces mRNA splice variant MBD2_v2 to promote stemness in TP53 wild‐type, African American PCa cells

por Teslow, Emily A., Bao, Bin, Dyson, Greg, Legendre, Christophe, Mitrea, Cristina, Sakr, Wael, Carpten, John D., Powell, Isaac, Bollig‐Fischer, Aliccia
Publicado 2018

Cytogenomic profiling of breast cancer brain metastases reveals potential for repurposing targeted therapeutics

por Bollig-Fischer, Aliccia, Michelhaugh, Sharon K., Wijesinghe, Priyanga, Dyson, Greg, Kruger, Adele, Palanisamy, Nallasivam, Choi, Lydia, Alosh, Baraa, Ali-Fehmi, Rouba, Mittal, Sandeep
Publicado 2015

Five advanced pancreatic cancer patients in a Phase I study of anti-CD3 x anti-EGFR bispecific antibody armed activated T cells (BATS)

por Lum, Lawrence G, Choi, Minsig, Thakur, Archana, Deol, Abhinav, Fields, Kristie, Tomaszewski, Elyse, Schalk, Dana, Kondadasule, Vidya, Dyson, Greg, Mahaseth, Hemchandra, Philip, Philip, Shields, Anthony
Publicado 2015

Treating triple negative breast cancer cells with erlotinib plus a select antioxidant overcomes drug resistance by targeting cancer cell heterogeneity

por Bao, Bin, Mitrea, Cristina, Wijesinghe, Priyanga, Marchetti, Luca, Girsch, Emily, Farr, Rebecca L., Boerner, Julie L, Mohammad, Ramzi, Dyson, Greg, Terlecky, Stanley R., Bollig-Fischer, Aliccia
Publicado 2017

Impact of positive cytology in uterine serous carcinoma: A reassessment

por Corey, Logan, Fucinari, Juliana, Elshaikh, Mohamed, Schultz, Daniel, Musallam, Rami, Zaiem, Feras, Daaboul, Fayez, Fehmi, Omar, Dyson, Greg, Ruterbusch, Julie, Morris, Robert, Cote, Michelle L., Ali-Fehmi, Rouba, Bandyopadhyay, Sudeshna
Publicado 2021